Canada Post Corporation Pension Plan’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.02M Hold
87,063
0.18% 111
2026
Q1
$5.28M Hold
87,063
0.21% 106
2025
Q4
$4.7M Buy
87,063
+22,986
+36% +$1.11M 0.18% 110
2025
Q3
$2.83M Sell
64,077
-1,634
-2% -$76.3K 0.13% 148
2025
Q2
$3.04M Buy
+65,711
New +$3.23M 0.18% 105
2025
Q1
Sell
-81,201
Closed -$4.59M 70
2024
Q4
$4.59M Buy
+81,201
New +$4.54M 0.27% 84

Other funds holding BMY

Canada Post Corporation Pension Plan's BMY Position: Q2 2026 in Review

Canada Post Corporation Pension Plan held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 87,063 shares worth $5.02M. The position accounts for 0.18% of the portfolio, ranked #111.

Canada Post Corporation Pension Plan first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.28M in Q1 2026. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Canada Post Corporation Pension Plan held 87,063 shares of Bristol-Myers Squibb worth $5.02M as of Q2 2026.
  • Canada Post Corporation Pension Plan left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.18% of Canada Post Corporation Pension Plan's portfolio in Q2 2026, its #111 holding.
  • Canada Post Corporation Pension Plan first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Canada Post Corporation Pension Plan's Bristol-Myers Squibb position peaked at $5.28M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Canada Post Corporation Pension Plan's 13F filing for Q2 2026, filed 15 Jul 2026.